Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G H Rao

Showing results (11-20 of 153) with videos related to

Pageof 16
Sort By:
American Journal of Hematology|December 1, 1981
Epinephrine potentiation of arachidonate-induced aggregation of cyclooxygenase-deficient plateletsG H Rao, J G White
Indian Journal of Physiology and Pharmacology|April 1, 1994
Pharmacology of platelet activation-inhibitory drugsG H Rao, A T Rao
Thrombosis Research|March 1, 1989
Influence of phospholipase A2 on human blood platelet alpha adrenergic receptor functionG H Rao, J G White
Biochemical Pharmacology|January 15, 1975
Influence of esterase inhibitors on platelet aggregation and release induced by phorbol myristate acetateG H Rao, J G White
Thrombosis Research|July 15, 1988
An improved method for measuring endogenous serotonin in platelets of patients with Hermansky-Pudlak syndromeG H Rao, J G White
Journal of Chromatography|September 26, 1973
Aflatoxin detection by high-speed liquid chromatography and mass spectrometryG H Rao, M W Anders
Prostaglandins, Leukotrienes, and Medicine|April 1, 1985
Comparative pharmacology of cyclooxygenase inhibitors on platelet functionG H Rao, J G White
American Journal of Hematology|August 1, 1985
Role of arachidonic acid metabolism in human platelet activation and irreversible aggregationG H Rao, J G White
Prostaglandins, Leukotrienes, and Medicine|October 1, 1982
Platelet activating factor (PAF) causes human platelet aggregation through the mechanism of membrane modulationG H Rao, J G White
Thrombosis Research|November 15, 1996
Aggregated-disaggregated, refractory platelets retain sensitivity to ristocetinJ G White, G H Rao
Pageof 16

Showing results (11-20 of 153) with videos related to

Sort By:
Pageof 16
American Journal of Hematology|December 1, 1981
Epinephrine potentiation of arachidonate-induced aggregation of cyclooxygenase-deficient plateletsG H Rao, J G White
Indian Journal of Physiology and Pharmacology|April 1, 1994
Pharmacology of platelet activation-inhibitory drugsG H Rao, A T Rao
Thrombosis Research|March 1, 1989
Influence of phospholipase A2 on human blood platelet alpha adrenergic receptor functionG H Rao, J G White
Biochemical Pharmacology|January 15, 1975
Influence of esterase inhibitors on platelet aggregation and release induced by phorbol myristate acetateG H Rao, J G White
Thrombosis Research|July 15, 1988
An improved method for measuring endogenous serotonin in platelets of patients with Hermansky-Pudlak syndromeG H Rao, J G White
Journal of Chromatography|September 26, 1973
Aflatoxin detection by high-speed liquid chromatography and mass spectrometryG H Rao, M W Anders
Prostaglandins, Leukotrienes, and Medicine|April 1, 1985
Comparative pharmacology of cyclooxygenase inhibitors on platelet functionG H Rao, J G White
American Journal of Hematology|August 1, 1985
Role of arachidonic acid metabolism in human platelet activation and irreversible aggregationG H Rao, J G White
Prostaglandins, Leukotrienes, and Medicine|October 1, 1982
Platelet activating factor (PAF) causes human platelet aggregation through the mechanism of membrane modulationG H Rao, J G White
Thrombosis Research|November 15, 1996
Aggregated-disaggregated, refractory platelets retain sensitivity to ristocetinJ G White, G H Rao
Pageof 16